Claversal

Claversal is a rectal formulation of mesalazine, used for managing inflammatory conditions. This medication helps reduce inflammation in the rectum and colon, offering targeted relief.

Claversal, containing mesalazine, is primarily used for the treatment of inflammatory bowel diseases, particularly those affecting the rectum and colon. It is often prescribed for conditions like ulcerative proctitis or proctosigmoiditis. Mesalazine works locally to alleviate symptoms such as rectal pain, bleeding, and diarrhea, making it a key component in managing these conditions.

Common effects of Claversal may include mild rectal irritation or discomfort upon initial use. Some users might experience temporary changes in bowel movements. These effects are generally short-lived and tend to subside as the body adjusts to the medication.

Claversal should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions to avoid potential side effects. Individuals with known allergies to mesalazine or related compounds should avoid using this medication.

Claversal may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other rectal preparations. It is advisable to consult a healthcare provider before combining Claversal with other medications, especially if you are taking multiple treatments for inflammatory conditions.